| pubmed-article:18637156 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0878773 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C1876226 | lld:lifeskim |
| pubmed-article:18637156 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:18637156 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:18637156 | pubmed:dateCreated | 2008-9-12 | lld:pubmed |
| pubmed-article:18637156 | pubmed:abstractText | To evaluate the efficacy, safety/tolerability, and dose-response relationship of imidafenacin in Japanese patients with overactive bladder. | lld:pubmed |
| pubmed-article:18637156 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18637156 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18637156 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18637156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18637156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18637156 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18637156 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18637156 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:18637156 | pubmed:issn | 1442-2042 | lld:pubmed |
| pubmed-article:18637156 | pubmed:author | pubmed-author:HommaYukioY | lld:pubmed |
| pubmed-article:18637156 | pubmed:author | pubmed-author:YamaguchiTaku... | lld:pubmed |
| pubmed-article:18637156 | pubmed:author | pubmed-author:YamaguchiOsam... | lld:pubmed |
| pubmed-article:18637156 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18637156 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:18637156 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18637156 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18637156 | pubmed:pagination | 809-15 | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:meshHeading | pubmed-meshheading:18637156... | lld:pubmed |
| pubmed-article:18637156 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18637156 | pubmed:articleTitle | A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder. | lld:pubmed |
| pubmed-article:18637156 | pubmed:affiliation | Department of Urology, University of Tokyo, Tokyo, Japan. | lld:pubmed |
| pubmed-article:18637156 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18637156 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18637156 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18637156 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18637156 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
